World-class Performance with Assistance of Artificial Intelligence

STOCKHOLM, Dec. 12, 2019 /PRNewswire/ — In the latest version of Ortoma Treatment Solution, OTS 4, Ortoma has introduced support of Artificial Intelligence. The system drastically reduces the time needed for pre-operatively planning of a hip implant in 3D, which has created a big interest for the company’s unique solution. 

Performance has been a focus area during the development of the latest version of Ortoma Treatment Solution (OTS). With OTS 4, an automatic AI-analysis, which forms the basis for the pre-operative planning, is made. The analysis does not take more than about 30 seconds and includes a suggestion for suitable implant and its optimized position. The surgeon can adjust and verify the result in a simple and intuitive workflow, which only takes a few minutes. This can be compared to other systems, which can take up to 30 minutes to perform the same process.

Linus Byström, CEO, comments: “The upgrade of OTS with support of AI exceeds our high ambitions. A pre-operative planning in 3D can now be done substantially quicker than before. It contributes to consistent and optimal result of the treatment outcome.”

OTS 4 with support of AI is CE marked for the European market, and surgeries where the system was used have been performed in Sweden. The company is planning to file an application for marketing approval in USA and selected markets in Asia. Prioritization between countries is on-going.

Ortoma Treatment Solution™ – careful planning and precise surgery.

For more information, please contact:
Ortomas CEO Linus Byström or Chairman of the board Gunnar Németh

This information was brought to you by Cision,c2988427

The following files are available for download: release in PDF


Print Friendly, PDF & Email

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

One Comment

Back to top button